Autoantibodies in recent onset type-1 diabetic patients to a Mr 60K microsomal hepatic protein: new evidence for autoantibodies to the type-2 glucosetransporter
M. Pehuet-figoni et al., Autoantibodies in recent onset type-1 diabetic patients to a Mr 60K microsomal hepatic protein: new evidence for autoantibodies to the type-2 glucosetransporter, CLIN EXP IM, 122(2), 2000, pp. 164-169
Here we describe the presence of IgG antibodies, in the sera of patients pr
esenting with insulin-dependent diabetes mellitus (IDDM), that react in Wes
tern blots with a 60-kD protein (Mr 60K) from rat hepatic microsomal extrac
ts. Sera from 60 IDDM patients were screened and 31.6% were positive for th
e Mr 60K band. This antibody reactivity was indistinguishable in terms of b
oth molecular weight and isoelectric point (pI 5.4) from that described in
some patients presenting with autoimmune hepatitis who may also develop IDD
M. We hypothesized that the type-2 glucose transporter (Glut-2) that is exp
ressed on both hepatocytes and pancreatic beta cells could be a putative ta
rget for the detected antibodies. A polyclonal antisera to rat Glut-2 used
in the liver microsome Western blot identified a 60-kD band superimposable
upon that evidenced by IDDM sera. Antisera to Glut-2 successfully inhibited
the binding of the patient's IgGs to liver microsomes, further suggesting
that the two proteins may be identical. Using protein extracts from a rat i
nsulinoma cell line (RIN) transfected with the human Glut-2 cDNA, further e
vidence was obtained suggesting that these IDDM IgGs are specific for the h
uman Glut-2 transporter.